Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau …
Résumé Contexte Le Réseau canadien pour les traitements de l'humeur et de l'anxiété
(CANMAT) a publié les dernières lignes directrices cliniques pour le traitement du trouble …
(CANMAT) a publié les dernières lignes directrices cliniques pour le traitement du trouble …
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
RL Dean, C Hurducas, K Hawton… - Cochrane Database …, 2021 - cochranelibrary.com
Background Many studies have recently been conducted to assess the antidepressant
efficacy of glutamate modification in mood disorders. This is an update of a review first …
efficacy of glutamate modification in mood disorders. This is an update of a review first …
[HTML][HTML] Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant …
S Bulteau, A Laurin, M Pere, G Fayet… - Brain Stimulation, 2022 - Elsevier
Background Recently intermittent theta burst stimulation (iTBS) proved to be non-inferior to
conventional repetitive transcranial magnetic stimulation (10 Hz rTMS) in unipolar …
conventional repetitive transcranial magnetic stimulation (10 Hz rTMS) in unipolar …
How does borderline personality disorder affect management and treatment response of patients with major depressive disorder? A comprehensive review
A Ceresa, CM Esposito, M Buoli - Journal of affective disorders, 2021 - Elsevier
Abstract Background Borderline Personality Disorder (BPD) and Major Depressive Disorder
(MDD) are two clinical conditions that often co-occur, sharing several neurobiological …
(MDD) are two clinical conditions that often co-occur, sharing several neurobiological …
[HTML][HTML] Serotonin Type 3 Receptor Is Potentially Involved in Cellular Stress Induced by Hydrogen Peroxide
AS Correia, I Silva, JC Oliveira, H Reguengo, N Vale - Life, 2022 - mdpi.com
Depression is a disease with several molecular mechanisms involved, such as problems in
the serotonergic pathway. This disease is very complex and prevalent, and thus important to …
the serotonergic pathway. This disease is very complex and prevalent, and thus important to …
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and …
A Yrondi, H Javelot, B Nobile, L Boudieu, B Aouizerate… - L'encephale, 2024 - Elsevier
Introduction The purpose of this update is to add newly approved nomenclatures and
treatments as well as treatments yet to be approved in major depressive disorder, thus …
treatments as well as treatments yet to be approved in major depressive disorder, thus …
Common practical questions–and answers–at the British Association for Psychopharmacology child and adolescent psychopharmacology course
S Cortese, FMC Besag, B Clark… - Journal of …, 2023 - journals.sagepub.com
The British Association for Psychopharmacology course on child and adolescent
psychopharmacology has been run for more than 20 years and is currently a very popular …
psychopharmacology has been run for more than 20 years and is currently a very popular …
[HTML][HTML] Antidepressant effect of repetitive transcranial magnetic stimulation is not impaired by intake of lithium or antiepileptic drugs
T Hebel, MA Abdelnaim, M Deppe, PM Kreuzer… - European Archives of …, 2021 - Springer
Introduction The effect of concomitant medication on repetitive transcranial magnetic
stimulation (rTMS) outcomes in depression remains understudied. Recent analyses show …
stimulation (rTMS) outcomes in depression remains understudied. Recent analyses show …
Association of optimal lamotrigine serum levels and therapeutic efficacy in mood disorders: A systematic review
R Kumar, NA Nuñez, LJ Prokop, M Veldic… - Journal of Clinical …, 2021 - journals.lww.com
Purpose The aim of the study was to appraise the current evidence on the optimal serum
level for lamotrigine (LAM) in the treatment of mood disorders (major depressive disorder …
level for lamotrigine (LAM) in the treatment of mood disorders (major depressive disorder …
[PDF][PDF] Thoughtful prescribing for patients with difficult-to-treat depression
A Soubolsky, J Visentin, A Crawley - Canadian Family Physician, 2023 - cfp.ca
Approximately 1 in 20 Canadians are diagnosed with it each year, and it is the second
highest cause of disability worldwide. 1 Nonresponse to treatment is common, with response …
highest cause of disability worldwide. 1 Nonresponse to treatment is common, with response …